Mirum Pharmaceuticals
Income Statement
Last updated:
Income statement is a financial statement that shows how profitable a business was over a given reporting period presenting its revenue, expenses or net income. Mirum Pharmaceuticals's past years’ income statements indicate that its last revenue has increased compared to the previous period by 142% to $186,374,000. Profit margin reached -88%. Total operating expenses were $248,489,000.
Profit Margin
| 2019 | 0 | -52.55M | |
|---|---|---|---|
| 2020 | 0 | -103.27M | |
| 2021 | 19.13M | -83.98M | -438.85% |
| 2022 | 77.06M | -135.66M | -176.05% |
| 2023 | 186.37M | -163.41M | -87.68% |
MIRM Income Statement (2019 – 2023)
| 2023 | 2022 | 2021 | 2020 | 2019 | |
|---|---|---|---|---|---|
Revenue | |||||
Revenue | 186.37M | 77.06M | 19.13M | 0 | 0 |
Cost of revenue | 47.03M | 12.37M | 1.90M | 623K | 324K |
Gross profit | 139.33M | 64.68M | 17.23M | -623K | -324K |
Operating exp. | |||||
Research and development | 102.60M | 106.84M | 131.42M | 81.60M | 42.99M |
Selling and marketing | 6.3M | 72.10M | 9.2M | 0 | 0 |
Total operating expenses | 248.48M | 195.90M | 190.64M | 104.29M | 54.74M |
Operating income | -109.15M | -131.22M | -173.41M | -104.29M | -54.74M |
Other income (expenses), net | -53.27M | -10.85M | 89.46M | 1.03M | 2.21M |
Income before tax | -162.42M | -142.07M | -83.95M | -103.26M | -52.53M |
Income tax expense | 991K | -6.40M | 37K | 6K | 21K |
Net income | -163.41M | -135.66M | -83.98M | -103.27M | -52.55M |
Earnings per share | |||||
Basic EPS | -4 | -4.01 | -2.77 | -4.09 | -2.29 |
Diluted EPS | -4 | -4.01 | -2.77 | -4.09 | -2.29 |
| Data source | Data source | Data source | Data source | Data source |